| Richard B. Berry, MD |
Fig. 01 -
Title Slide
Fig. 02 -
Co-investigators
Fig. 03 -
Disclosures
Fig. 04 -
POSA Definitions
Fig. 05 -
NightBalance SPT Device
Fig. 06 -
SPT Device (Continued)
Fig. 07 -
Smart Device
Fig. 08 -
Proven Effective
Fig. 09 -
Study Design
Fig. 10 -
Trial Hypotheses
Fig. 11 -
Quality of Life
Fig. 12 -
Inclusion Criteria
Fig. 13 -
Qualifying PSG
Fig. 14 -
Exclusion Criteria
Fig. 15 -
Treatment PSG
Fig. 16 -
APAP Treatment
Fig. 17 -
SPT Treatment
Fig. 18 -
Patient Flow
Fig. 19 -
Demographics and DATA
Fig. 20 -
Baseline Data
Fig. 21 -
Treatment PSG DATA
Fig. 22 -
No Difference
Fig. 23 -
Lower Arousal Index
Fig. 24 -
Sleep Stages
Fig. 25 -
Position and Respiratory
Fig. 26 -
AHI Difference (SPT-APAP)
Fig. 27 -
Effect of Body Position
Fig. 28 -
Versus
Fig. 29 -
Were NOT Different
Fig. 30 -
Oxygenation PSG Data
Fig. 31 -
Measures
Fig. 32 -
Outcomes
Fig. 33 -
Adherence Data
Fig. 34 -
Device Adherence Data
Fig. 35 -
Patient Preference
Fig. 36 -
Patient Device Preference
Fig. 37 -
Summary
Fig. 38 -
Conclusions
Fig. 39 -
Thank You
TODO, let Pete know of any updates to this content
Six (6) provocative statements concerning clinical treatment of IBD. Each statement is presented as 5 steps:Step 1: the statement & introduction, + 5 possible opinions of that statement -- please choose one
Step 2: a graph of an international survey’s opinions of that statement
Step 3: a literature review for that statement
Step 4: a graph comparing the faculty's vs an international survey’s opinions, + faculty discussion
Step 5: a brief faculty summary, plus the list of references.
Please click on any Statement or any Step tab to read this publication in the order you prefer.